Rocket One Inc. Gain (Loss) on Termination of Lease
Rocket One Inc. (RKTO) reported Gain (Loss) on Termination of Lease of $1.03 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnTerminationOfLease · last filed 2026-08-14
- Rocket One Inc. gain (loss) on termination of lease for the quarter ending 2026-03-31 was $1.03K.
- Rocket One Inc. gain (loss) on termination of lease for the quarter ending 2025-03-31 was -$4.35K.
- Rocket One Inc. gain (loss) on termination of lease for fiscal 2025 was -$850.50K.
- Rocket One Inc. gain (loss) on termination of lease for fiscal 2023 was $275.00K.
| Period end | Gain (Loss) on Termination of Lease 3 month | Gain (Loss) on Termination of Lease 3 month as first filed | Gain (Loss) on Termination of Lease 6 month | Gain (Loss) on Termination of Lease 6 month as first filed | Gain (Loss) on Termination of Lease 9 month | Gain (Loss) on Termination of Lease 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.03K 10-Q · filed 2026-08-14 | |||||
| 2026-03-31 | $1.03K 10-Q · filed 2026-05-15 | |||||
| 2025-12-31 | -$850.50K 10-K · filed 2026-03-27 | |||||
| 2025-09-30 | -$850.50K 10-Q · filed 2025-11-12 | |||||
| 2025-06-30 | -$3.25K 10-Q · filed 2026-08-14 | -$850.50K 10-Q · filed 2025-08-12 | ||||
| 2025-03-31 | -$4.35K 10-Q · filed 2026-05-15 | -$850.50K 10-Q · filed 2025-05-12 | ||||
| 2023-12-31 | $275.00K 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |